Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neurogenetics is Scopus-indexed (Q3, CiteScore 2.4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 1364-6745Verify ISSN ↗1364-6753Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: About US$4,590 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 72 / 100 | 28th | Q3 |
| Genetics | 276 / 357 | 22nd | Q4 |
| Cellular and Molecular Neuroscience | 86 / 102 | 16th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1997–present, best quartile Q3, CiteScore 2.4.
Neurogenetics is Q3 in Genetics (clinical) (rank 72 of 100), Q4 in Genetics (rank 276 of 357) and Q4 in Cellular and Molecular Neuroscience (rank 86 of 102), by CiteScore 2025.
Neurogenetics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.4, which places it in quartile Q3 at the 28th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.703, quartile Q3, with an H-index of 72.
The publisher lists an article processing charge of about US$4,590 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Neurogenetics is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 1364-6745 and its online ISSN is 1364-6753.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Neurogenetics has an h-index of 83 and a 2-year mean of 1.93 citations per paper (OpenAlex). Its Scopus CiteScore is 2.4, quartile Q3. On 2-year citations it ranks #54 of 99 Scopus journals in Genetics (clinical).
Neurogenetics published 76 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (17.8%), Türkiye (13.5%) and India (9.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (3.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.